PA
CLVS
Perceptive Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Hold |
0
| – | – | – | 119 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 120 |
|
|
2018
Q4 | – | Sell |
-150,000
| Closed | -$4.41M | – | 130 |
|
|
2018
Q3 | $4.41M | Buy |
+150,000
| New | +$4.41M | 0.12% | 73 |
|
|
2017
Q2 | – | Sell |
-157,754
| Closed | -$10M | – | 165 |
|
|
2017
Q1 | $10M | Sell |
157,754
-10,000
| -6% | -$637K | 0.57% | 42 |
|
|
2016
Q4 | $7.45M | Sell |
167,754
-3,746
| -2% | -$166K | 0.53% | 48 |
|
|
2016
Q3 | $6.18M | Buy |
+171,500
| New | +$6.18M | 0.4% | 58 |
|
|
2015
Q1 | – | Sell |
-5,138
| Closed | -$288K | – | 174 |
|
|
2014
Q4 | $288K | Sell |
5,138
-25,779
| -83% | -$1.44M | 0.02% | 109 |
|
|
2014
Q3 | $1.4M | Buy |
30,917
+20,000
| +183% | +$907K | 0.14% | 72 |
|
|
2014
Q2 | $452K | Sell |
10,917
-161,300
| -94% | -$6.68M | 0.04% | 81 |
|
|
2014
Q1 | $11.9M | Buy |
172,217
+141,632
| +463% | +$9.81M | 1.25% | 23 |
|
|
2013
Q4 | $1.84M | Sell |
30,585
-164,116
| -84% | -$9.89M | 0.22% | 52 |
|
|
2013
Q3 | $11.8M | Buy |
194,701
+53,874
| +38% | +$3.28M | 0.96% | 23 |
|
|
2013
Q2 | $9.43M | Buy |
+140,827
| New | +$9.43M | 0.95% | 21 |
|